| Preparation of Diphtheria Prophylactic |
| | | | |
| Alum Precipitated Toxoid (A.P.T.) B.P. |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|
| Formal Toxoid (F.T.) B.P. |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|
| Purified Toxoid Aluminium Phosphate (P.T.A.P.) B.P. |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|
| Diphtheria and Pertussis Vaccine B.P. |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|
| Toxoid Anti-toxin Floccules (Commercial preparation: no official standards available) |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|
| Diphtheria-Tetanus-Pertussis Vaccine (D.T.P.) B.P. |
| | | Dose recommended by the manufacturer or prescribed in the British Pharmacopaeia |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer or prescribed in the British Pharmacopaeia |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|
| Diphtheria Tetanus Vaccine (D.T.) B.P. |
| | | Dose recommended by the manufacturer or prescribed in the British Pharmacopaeia |
| | Deep Subcutaneous or Intramuscular |
| |
| | | Dose recommended by the manufacturer or prescribed in the British Pharmacopaeia |
| | Deep Subcutaneous or Intramuscular |
| | As prescribed in regulation 4 of the Regulations |
|